 |
 |

Argon Green vs Krypton Red Laser Photocoagulation of Extrafoveal Choroidal Neovascular LesionsOne-Year Results in Age-Related Macular Degeneration
The Canadian Ophthalmology Study Group
Arch Ophthalmol. 1993;111(2):181-185.
Abstract
This multicenter randomized controlled clinical trial performed in Canada was designed to determine whether krypton red laser or argon green laser is superior for treatment of choroidal neovascularization located between 200 and 2500µm from the center of the foveal avascular zone in patients with agerelated macular degeneration. Two hundred ten patients were randomly assigned to treatment with either argon green or krypton red laser, of whom 191 (91%) were determined eligible. Of the eligible patients, 185 (97%) had sufficient follow-up for a comparison of primary-outcome visual acuity at 1 year. We conclude, with 95% confidence, that the krypton red laser is no better than the argon green laser for the treatment of well-defined extrafoveal choroidal neovascularization.
Author Affiliations
A complete listing of the participants in the Canadian Ophthalmology Study Group (COSG) appears on page 185. The COSG has no proprietary interest in either the argon green laser or the krypton red laser.
Footnotes
Accepted for publication July 31, 1992.
Prepared for the COSG by Alan F. Cruess, MD; Andrew Willan, PhD; and Margaret Ballantyne, MS, Queen's University, Kingston, Ontario.
Reprint requests to COSG, Room 3011, Etherington Hall, Queen's University, Kingston, Ontario, Canada K7L 3N6 (Dr Cruess).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Argon Green vs Krypton Red Laser Photocoagulation for Extrafoveal Choroidal Neovascularization: One-Year Results in Ocular Histoplasmosis
The Canadian Ophthalmology Study Group
Arch Ophthalmol 1994;112:1166-1173.
ABSTRACT
Evaluation of Argon Green vs Krypton Red Laser for Photocoagulation of Subfoveal Choroidal Neovascularization in the Macular Photocoagulation Study
Macular Photocoagulation Study (MPS) Group
Arch Ophthalmol 1994;112:1176-1184.
ABSTRACT
Does Wavelength Matter When Photocoagulating Eyes With Macular Degeneration or Diabetic Retinopathy?
Bressler
Arch Ophthalmol 1993;111:177-180.
ABSTRACT
|